Jin Piao, PhD

Title(s)Associate Professor of Clinical Population and Public Health Sciences
SchoolKeck School of Medicine of Usc
Address1845 N. Soto Street
Health Sciences Campus
Los Angeles CA 90032
Phone+1 626 241 1572
Emailjpiao@usc.edu
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    The University of Texas Health Science Center at HoustonDoctor of Philosophy (Ph.D.)08/2017Biostatistics
    University of ToledoMaster's degree05/2012Mathematics
    Tongji UniversityBachelor of Science (BS)08/2010Statistics

    Collapse Overview 
    Collapse overview
    Dr. Jin Piao is an Associate Professor from the Division of Biostatistics, Department of Population and Public Health Sciences, the University of Southern California. She has been working on the development of methodological approaches that have direct impacts on biomedical applications. Her research interest lies in the areas including clinical trial design and analysis, survival analysis, semiparametric statistical models, and meta-analysis. In addition to statistical methodological research, she has been actively collaborated with physicians and biologists in pediatric solid tumors areas and supported several phases I, II, or III solid tumors clinical trials at Children’s Oncology Group.

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. On the use of external controls in clinical trials. J Natl Cancer Inst Monogr. 2025 Mar 01; 2025(68):30-34. Nuño MM, Pugh SL, Ji L, Piao J, Dignam JJ, Steingrimsson JA. PMID: 39989040; PMCID: PMC11848027.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Upfront or delayed surgery in resectable hepatoblastoma: analysis from the children's hepatic tumors international collaboration database. EClinicalMedicine. 2024 Oct; 76:102811. Hiyama E, Hishiki T, Yoshimura K, Krailo M, Maibach R, Haeberle B, Rangaswami A, Lopez-Terrada D, Malogolowkin MH, Ansari M, Alaggio R, O'Neill AF, Trobaugh-Lotrario AD, Watanabe K, Schmid I, Ranganathan S, Tanaka Y, Inoue T, Piao J, Lin J, Czauderna P, Meyers RL, Aronson DC. PMID: 39309724; PMCID: PMC11414700.
      View in: PubMed   Mentions:
    3. Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I). JCO Precis Oncol. 2024 Sep; 8:e2400418. Macy ME, Mody R, Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Fox E, Weigel BJ, Hawkins DS, Mooney MM, Williams PM, Patton DR, Coffey BD, Roy-Chowdhuri S, Takebe N, Tricoli JV, Janeway KA, Seibel NL, Parsons DW. PMID: 39298716; PMCID: PMC11488755.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    4. Phase II Study of Samotolisib in Children and Young Adults With Tumors Harboring Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Pathway Alterations: Pediatric MATCH APEC1621D. JCO Precis Oncol. 2024 Sep; 8:e2400258. Laetsch TW, Ludwig K, Williams PM, Roy-Chowdhuri S, Patton DR, Coffey B, Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Mhlanga J, Fox E, Weigel BJ, Hawkins DS, Mooney MM, Takebe N, Tricoli JV, Janeway KA, Seibel NL, Parsons DW. PMID: 39298693; PMCID: PMC11581706.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    5. Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G. Oncologist. 2024 Aug 05; 29(8):723-e1093. Nelson MV, Kim A, Williams PM, Roy-Chowdhuri S, Patton DR, Coffey BD, Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Ramirez NC, Jaju A, Fox E, Weigel BJ, Hawkins DS, Mooney MM, Takebe N, Tricoli JV, Janeway KA, Seibel NL, Parsons DW. PMID: 38873934; PMCID: PMC11299954.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    6. Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trial. Oncologist. 2024 Jul 05; 29(7):638-e952. Glade Bender JL, Pinkney K, Williams PM, Roy-Chowdhuri S, Patton DR, Coffey BD, Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Ramirez NC, Fox E, Weigel BJ, Hawkins DS, Mooney MM, Takebe N, Tricoli JV, Janeway KA, Seibel NL, Parsons DW. PMID: 38815151; PMCID: PMC11224971.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    7. Phase II Study of Ulixertinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Alterations: APEC1621J of the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial. JCO Precis Oncol. 2024 Jun; 8:e2400103. Vo KT, Sabnis AJ, Williams PM, Roy-Chowdhuri S, Patton DR, Coffey B, Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Jaju A, Fox E, Weigel BJ, Hawkins DS, Mooney MM, Takebe N, Tricoli JV, Janeway KA, Seibel NL, Parsons DW. PMID: 38935895; PMCID: PMC11639582.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsCTClinical Trials
    8. Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C. J Natl Cancer Inst. 2023 11 08; 115(11):1355-1363. Chi SN, Yi JS, Williams PM, Roy-Chowdhuri S, Patton DR, Coffey BD, Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Ramirez NC, Jaju A, Mhlanga JC, Fox E, Hawkins DS, Mooney MM, Takebe N, Tricoli JV, Janeway KA, Seibel NL, Parsons DW. PMID: 37228094; PMCID: PMC11009504.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    9. A multi-institutional feasibility study of intra-arterial chemotherapy in children with retinoblastoma. A Children's Oncology Group study (COG ARET12P1). Pediatr Blood Cancer. 2024 Jan; 71(1):e30718. Chintagumpala M, Piao J, Gombos D, Chevez-Barrios P, Brock L, Dunkel IJ, Jubran R, Leahey AM, Kim J, O'Brien J, Shields CL, Rodriguez-Galindo C. PMID: 37817345; PMCID: PMC10842937.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Rare Tumors: Opportunities and challenges from the Children's Oncology Group perspective. EJC Paediatr Oncol. 2023 Dec; 2. Schultz KAP, Chintagumpala M, Piao J, Chen KS, Shah R, Gartrell RD, Christison-Lagay E, Pashnakar F, Berry JL, O'Neill AF, Vasta LM, Flynn A, Mitchell SG, Seynnaeve BK, Rosenblum J, Potter SL, Kamihara J, Rodriguez-Galindo C, Hawkins DS, Laetsch TW. PMID: 37829670; PMCID: PMC10566015.
      View in: PubMed   Mentions: 4  
    11. Children's Oncology Group's 2023 blueprint for research: Rare tumors. Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30574. Schultz KAP, Chintagumpala M, Piao J, Chen KS, Gartrell R, Christison-Lagay E, Berry JL, Shah R, Laetsch TW, Children's Oncology Group Rare Tumor Committee. PMID: 37458616; PMCID: PMC10529839.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Refining the serum miR-371a-3p test for viable germ cell tumor detection. Sci Rep. 2023 06 29; 13(1):10558. Lafin JT, Scarpini CG, Amini A, Konneh B, Howard JM, Gerald T, Nuno M, Piao J, Savelyeva A, Wang Z, Gagan J, Jia L, Lewis CM, Murray S, Sawa YC, Margulis V, Woldu SL, Strand DW, Coleman N, Amatruda JF, Frazier AL, Murray MJ, Bagrodia A. PMID: 37386046; PMCID: PMC10310745.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    13. Vincristine/irinotecan/temsirolimus upfront window treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 Study Committee. Pediatr Blood Cancer. 2023 07; 70(7):e30365. Thompson PA, Malogolowkin MH, Furman WL, Piao J, Krailo MD, Chung N, Brock L, Towbin AJ, McCarville EB, Finegold MJ, Ranganathan S, Dunn SP, Langham MR, McGahren ED, Tiao GM, Weldon CB, O'Neill AF, Rodriguez-Galindo C, Meyers RL, Katzenstein HM. PMID: 37073741; PMCID: PMC10205685.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    14. Refining the serum miR-371a-3p test for viable germ cell tumor detection: identification and definition of an indeterminate range. Res Sq. 2023 Mar 21. Lafin J, Scarpini C, Amini A, Konneh B, Howard J, Gerald T, Nuno M, Piao J, Savelyeva A, Wang Z, Gagan J, Jia L, Lewis C, Murray S, Sawa Y, Margulis V, Woldu S, Strand D, Coleman N, Amatruda J, Frazier L, Murray M, Bagrodia A. PMID: 36993198; PMCID: PMC10055551.
      View in: PubMed   Mentions:
    15. Intensive Multimodality Therapy for Extraocular Retinoblastoma: A Children's Oncology Group Trial (ARET0321). J Clin Oncol. 2022 11 20; 40(33):3839-3847. Dunkel IJ, Piao J, Chantada GL, Banerjee A, Abouelnaga S, Buchsbaum JC, Merchant TE, Granger MM, Jubran RF, Weinstein JL, Saguilig L, Abramson DH, Krailo MD, Rodriguez-Galindo C, Chintagumpala MM. PMID: 35820112; PMCID: PMC9671757.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    16. Outcomes of children with well-differentiated fetal hepatoblastoma treated with surgery only: Report from Children's Oncology Group Trial, AHEP0731. J Pediatr Surg. 2022 Oct; 57(10):251-256. Vasudevan SA, Meyers RL, Finegold MJ, López-Terrada D, Ranganathan S, Dunn SP, Langham MR, McGahren ED, Tiao GM, Weldon CB, Malogolowkin MH, Krailo MD, Piao J, Randazzo J, Towbin AJ, BethMcCarville M, O'Neill AF, Furman WL, Rodriguez-Galindo C, Katzenstein HM. PMID: 35810020; PMCID: PMC9474653.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    17. Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial. J Clin Oncol. 2022 07 10; 40(20):2235-2245. Eckstein OS, Allen CE, Williams PM, Roy-Chowdhuri S, Patton DR, Coffey B, Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Ramirez NC, Jaju A, Mhlanga J, Fox E, Hawkins DS, Mooney MM, Takebe N, Tricoli JV, Janeway KA, Seibel NL, Parsons DW. PMID: 35363510; PMCID: PMC9273373.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    18. Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial. J Clin Oncol. 2022 07 10; 40(20):2224-2234. Parsons DW, Janeway KA, Patton DR, Winter CL, Coffey B, Williams PM, Roy-Chowdhuri S, Tsongalis GJ, Routbort M, Ramirez NC, Saguilig L, Piao J, Alonzo TA, Berg SL, Fox E, Hawkins DS, Abrams JS, Mooney M, Takebe N, Tricoli JV, Seibel NL, NCI-COG Pediatric MATCH Team. PMID: 35353553; PMCID: PMC9273376.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCTClinical Trials
    19. Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee. J Clin Oncol. 2022 02 10; 40(5):459-467. Trobaugh-Lotrario A, Katzenstein HM, Ranganathan S, Lopez-Terrada D, Krailo MD, Piao J, Chung N, Randazzo J, Malogolowkin MH, Furman WL, McCarville EB, Towbin AJ, Tiao GM, Dunn SP, Langham MR, McGahren ED, Feusner J, Rodriguez-Galindo C, Meyers RL, O'Neill AF, Finegold MJ. PMID: 34874751; PMCID: PMC8824398.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    20. Doxorubicin in combination with cisplatin, 5-flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children's Oncology Group study. Cancer. 2022 03 01; 128(5):1057-1065. Katzenstein HM, Malogolowkin MH, Krailo MD, Piao J, Towbin AJ, McCarville MB, Tiao GM, Dunn SP, Langham MR, McGahren ED, Finegold MJ, Ranganathan S, Weldon CB, Thompson PA, Trobaugh-Lotrario AD, O'Neill AF, Furman WL, Chung N, Randazzo J, Rodriguez-Galindo C, Meyers RL. PMID: 34762296; PMCID: PMC9066555.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    21. A Multi-institutional Pooled Analysis Demonstrates That Circulating miR-371a-3p Alone is Sufficient for Testicular Malignant Germ Cell Tumor Diagnosis. Clin Genitourin Cancer. 2021 12; 19(6):469-479. Piao J, Lafin JT, Scarpini CG, Nuño MM, Syring I, Dieckmann KP, Belge G, Ellinger J, Amatruda JF, Bagrodia A, Coleman N, Krailo MD, Frazier AL, Murray MJ. PMID: 34629299; PMCID: PMC9084514.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    22. EMBRACE: An EM-based bias reduction approach through Copas-model estimation for quantifying the evidence of selective publishing in network meta-analysis. Biometrics. 2022 06; 78(2):754-765. Marks-Anglin A, Luo C, Piao J, Gibbons MBC, Schmid CH, Ning J, Chen Y. PMID: 33559881.
      View in: PubMed   Mentions: 2     Fields:    
    23. Imaging Appearance of Nongerminoma Pediatric Ovarian Germ Cell Tumors Does Not Discriminate Benign from Malignant Histology. J Pediatr Adolesc Gynecol. 2021 Jun; 34(3):383-386. Billmire D, Dicken B, Rescorla F, Ross J, Piao J, Huang L, Krailo M, Pashankar F, Frazier L, Children's Oncology Group. PMID: 33316416; PMCID: PMC8096645.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    24. Semiparametric isotonic regression modelling and estimation for group testing data. Can J Stat. 2021 Sep; 49(3):659-677. Yuan A, Piao J, Ning J, Qin J. PMID: 34690407; PMCID: PMC8528191.
      View in: PubMed   Mentions:
    25. A single-arm study of systemic and sub-Tenon chemotherapy for Groups C and D intraocular retinoblastoma: A Children's Oncology Group study (ARET 0231). Pediatr Blood Cancer. 2020 09; 67(9):e28502. Jubran RF, Villablanca JG, Krailo M, Piao J, Huang L, Murphree AL, O'Brien J, Gombos D, Shields CL, Meadows A, Chintagumpala M. PMID: 32589362; PMCID: PMC7857974.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    26. The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration (CHIC) database. Pediatr Blood Cancer. 2020 08; 67(8):e28350. Haeberle B, Rangaswami A, Krailo M, Czauderna P, Hiyama E, Maibach R, Lopez-Terrada D, Aronson DC, Alaggio R, Ansari M, Malogolowkin MH, Perilongo G, O'Neill AF, Trobaugh-Lotrario AD, Watanabe K, Schmid I, von Schweinitz D, Ranganathan S, Yoshimura K, Hishiki T, Tanaka Y, Piao J, Feng Y, Rinaldi E, Saraceno D, Derosa M, Meyers RL. PMID: 32383794.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    27. Trial Design Challenges and Approaches for Precision Oncology in Rare Tumors: Experiences of the Children's Oncology Group. JCO Precis Oncol. 2019; 3. Renfro LA, Ji L, Piao J, Onar-Thomas A, Kairalla JA, Alonzo TA. PMID: 32923863; PMCID: PMC7446492.
      View in: PubMed   Mentions: 14     Fields:    
    28. Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study. J Clin Oncol. 2019 11 01; 37(31):2883-2891. Chévez-Barrios P, Eagle RC, Krailo M, Piao J, Albert DM, Gao Y, Vemuganti G, Ali MJ, Khetan V, Honavar SG, O'Brien J, Leahey AM, Matthay K, Meadows A, Chintagumpala M. PMID: 31539297; PMCID: PMC6823888.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    29. Response adaptive randomization procedures in seamless phase II/III clinical trials. J Biopharm Stat. 2020; 30(1):3-17. Zhu H, Piao J, Lee JJ, Hu F, Zhang L. PMID: 31454295; PMCID: PMC6957739.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic features. Mod Pathol. 2020 03; 33(3):496-513. Nagarajan P, Piao J, Ning J, Noordenbos LE, Curry JL, Torres-Cabala CA, Diwan AH, Ivan D, Aung PP, Ross MI, Royal RE, Wargo JA, Wang WL, Samdani R, Lazar AJ, Rashid A, Davies MA, Prieto VG, Gershenwald JE, Tetzlaff MT. PMID: 31383963.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    31. Evaluation of the diagnostic biopsy approach for children with hepatoblastoma: A report from the children's oncology group AHEP 0731 liver tumor committee. J Pediatr Surg. 2020 Apr; 55(4):655-659. Weldon CB, Madenci AL, Tiao GM, Dunn SP, Langham MR, McGahren ED, Ranganathan S, López-Terrada DH, Finegold MJ, Malogolowkin MH, Piao J, Huang L, Krailo MD, Meyers RL, Katzenstein HM. PMID: 31126688; PMCID: PMC6842675.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    32. Semiparametric Model for Bivariate Survival Data Subject to Biased Sampling. J R Stat Soc Series B Stat Methodol. 2019 Apr; 81(2):409-429. Piao J, Ning J, Shen Y. PMID: 31435191; PMCID: PMC6703836.
      View in: PubMed   Mentions: 1  
    33. Prognosis of patients with intermediate risk IPSS-R myelodysplastic syndrome indicates variable outcomes and need for models beyond IPSS-R. Am J Hematol. 2018 10; 93(10):1245-1253. Benton CB, Khan M, Sallman D, Nazha A, Nogueras González GM, Piao J, Ning J, Aung F, Al Ali N, Jabbour E, Kadia TM, Borthakur G, Ravandi F, Pierce S, Steensma D, DeZern A, Roboz G, Sekeres M, Andreeff M, Kantarjian H, Komrokji RS, Garcia-Manero G. PMID: 30051599; PMCID: PMC6750209.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    34. Copas-like selection model to correct publication bias in systematic review of diagnostic test studies. Stat Methods Med Res. 2019 Oct-Nov; 28(10-11):2912-2923. Piao J, Liu Y, Chen Y, Ning J. PMID: 30062910; PMCID: PMC6443505.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    35. Semiparametric model and inference for spontaneous abortion data with a cured proportion and biased sampling. Biostatistics. 2018 01 01; 19(1):54-70. Piao J, Ning J, Chambers CD, Xu R. PMID: 28525542; PMCID: PMC5862342.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    36. Efficient two-stage designs and proper inference for animal studies. Stat Biosci. 2018 Apr; 10(1):217-232. Cai C, Piao J, Ning J, Huang X. PMID: 30294384; PMCID: PMC6168085.
      View in: PubMed   Mentions:
    37. Genetic heterogeneity of uncharacterized childhood autoimmune diseases with lymphoproliferation. Pediatr Blood Cancer. 2018 Feb; 65(2). Takagi M, Hoshino A, Yoshida K, Ueno H, Imai K, Piao J, Kanegane H, Yamashita M, Okano T, Muramatsu H, Okuno Y, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Ogawa S, Hayashi Y, Kojima S, Morio T. PMID: 28960754.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    38. Maximum likelihood estimation and EM algorithm of Copas-like selection model for publication bias correction. Biostatistics. 2017 Jul 01; 18(3):495-504. Ning J, Chen Y, Piao J. PMID: 28334132; PMCID: PMC5862358.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    39. Poly (ADP-ribose) polymerase inhibitors selectively induce cytotoxicity in TCF3-HLF-positive leukemic cells. Cancer Lett. 2017 02 01; 386:131-140. Piao J, Takai S, Kamiya T, Inukai T, Sugita K, Ohyashiki K, Delia D, Masutani M, Mizutani S, Takagi M. PMID: 27894958.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    40. Tumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 Cases. Clin Cancer Res. 2017 04 15; 23(8):2093-2104. Nagarajan P, Curry JL, Ning J, Piao J, Torres-Cabala CA, Aung PP, Ivan D, Ross MI, Levenback CF, Frumovitz M, Gershenwald JE, Davies MA, Malpica A, Prieto VG, Tetzlaff MT. PMID: 27864417.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    41. B7-H4 expression in ovarian serous carcinoma: a study of 306 cases. Hum Pathol. 2016 11; 57:1-6. Liang L, Jiang Y, Chen JS, Niu N, Piao J, Ning J, Zu Y, Zhang J, Liu J. PMID: 27349304; PMCID: PMC5077670.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    42. Recurrent event frailty models reduced time-varying and other biases in evaluating transfusion protocols for traumatic hemorrhage. J Clin Epidemiol. 2016 09; 77:52-59.e1. Choi S, Rahbar MH, Ning J, Del Junco DJ, Rahbar E, Hong C, Piao J, Fox EE, Holcomb JB. PMID: 27134138; PMCID: PMC5086300.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    43. A joint latent class model for classifying severely hemorrhaging trauma patients. BMC Res Notes. 2015 Oct 24; 8:602. Rahbar MH, Ning J, Choi S, Piao J, Hong C, Huang H, Del Junco DJ, Fox EE, Rahbar E, Holcomb JB. PMID: 26498438; PMCID: PMC4620016.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    44. A joint latent class analysis for adjusting survival bias with application to a trauma transfusion study. Stat Med. 2016 Jan 15; 35(1):65-77. Ning J, Rahbar MH, Choi S, Hong C, Piao J, del Junco DJ, Fox EE, Rahbar E, Holcomb JB. PMID: 26256455; PMCID: PMC4715697.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    45. Estimating the ratio of multivariate recurrent event rates with application to a blood transfusion study. Stat Methods Med Res. 2017 Aug; 26(4):1969-1981. Ning J, Rahbar MH, Choi S, Piao J, Hong C, Del Junco DJ, Rahbar E, Fox EE, Holcomb JB, Wang MC. PMID: 26160825; PMCID: PMC5088066.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    46. ATM-dependent DNA damage-response pathway as a determinant in chronic myelogenous leukemia. DNA Repair (Amst). 2013 Jul; 12(7):500-7. Takagi M, Sato M, Piao J, Miyamoto S, Isoda T, Kitagawa M, Honda H, Mizutani S. PMID: 23694754.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    Jin's Networks
    Concepts (195)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (18)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

    This site is running Profiles RNS version UCSF-v3.1.0-15-g9ae42700 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.